Enhanced interstitial expression of caldesmon in IgA nephropathy and its suppression by glucocorticoid-heparin therapy

Nephrology Dialysis Transplantation

Volumn 14, Issue 6, 1999, Pages 1408-1417

  Ando, Yutaka ^b   Moriyama, Toshiki ^b   Oka, Kazumasa ^b   Takatsuji, Koichi ^b   Miyazaki, Mutsuo ^b   Akagi, Yoshitaka ^b   Kawada, Noritaka ^b   Isaka, Yoshitaka ^b   Izumi, Masaaki ^b   Yokoyama, Kenji ^b   Yamauchi, Atsushi ^b   Horio, Masaru ^b   Ando, Akio ^b   Ueda, Naohiko ^b   Sobue, Kenji ^b   Imai, Enyu ^a   Hori, Masatsugu ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

Caldesmon; Glucocorticoid heparin therapy; IgA nephropathy; Interstitial cell; Myofibroblast; Phenotypic change

Indexed keywords

CALDESMON; CD68 ANTIGEN; GLUCOCORTICOID; HEPARIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; PRIORITY JOURNAL;

ACTINS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CALMODULIN-BINDING PROTEINS; GLOMERULONEPHRITIS, IGA; GLUCOCORTICOIDS; HEPARIN; HUMANS; KIDNEY; MICROSCOPY, IMMUNOELECTRON;

EID: 0033012869     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.6.1408     Document Type: Article

References (23)

1. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20: 1-17
2. Couser WG, Johonson RJ. Mechanisms of progressive renal disease in glomerulonephritis. Am J Kidney Dis 1994; 23: 193-198
3. Muller GA, Markovic-Lipkovski J, Rodemann HP. The progression of renal disease. On the pathogenesis of renal interstitial flbrosis. Klin Wochenschr 1991; 69: 576-586
4. Goumenos DS, C. B. B, Shortland J, El Nahas AM. Myofibroblasts, predictor of progression of mesangial IgA nephropathy? Nephrol Dial Transplant 1994; 9: 1418-1425
5. Desmouliere A, Gabbiani G. Myofibroblast differentiation during fibrosis. Exp Nephrol 1995; 3: 134-139
6. Sobue K, Marumoto Y, Fujita M, Kakiuchi S. Purification of a calmodulin-binding protein from chickengizzard that interacts with F-actin. Proc Natl Acad Sci USA 1981; 78: 5652-5655
7. Sobue K, Sellers JR. Caldesmon, a novel reguratory protein in smooth muscle and non muscle actomyosin system. J Biol Chem 1991; 266: 12115-12118
8. Ueki N, Sobue K, Kanda K, Hada K, Higashino K. Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc Natl Acad Sci USA 1987; 84: 9049-9053
9. Glukhova MA, Kabakov AE, Frid MG et al. Modulation of human aorta smooth muscle cell phenotype: A study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Natl Acad Sci USA 1988; 85: 9542-9546
10. Ando Y, Moriyama T, Miyazaki M et al. Enhanced glomerular expression of caldesmon in IgA nephropathy and its suppression by glucocorticoid-heparin therapy. Nephrol Dial Transplant 1998; 13: 1168-1175
11. Miguel-Hidalgo JJ, Senba E, Takatsuji K, Tohyama M. Fine structure of synapses and retinal innervation of substanse P and adenosin deaminase containing neurons in the superior colliculus of the rat. J Comp Neurol 1991; 303: 63-74
12. Hewitson TD, Becker GJ. Interstitial myofibroblasts in IgA glomerulonephritis. Am J Nephrol 1995; 15: 111-117
13. Hewitson D, Wu L, Becker GJ. Interstitial myofibroblasts in experimental renal infection and scarring. Am J Nephrol 1995; 15: 411-417
14. Muller GA, Rodemann HP. Characterization of human renal fibroblasts in health and disease: I. Immunophenotyping of cultured tubular epithelial cells and fibroblasts derived from kidneys with histologically proven interstitial fibrosis. Am J Kidney Dis 1991; 17: 680-683
15. Rodemann HP, Muller GA. Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am J Kidney Dis 1991; 17: 684-686
16. Ronnov-Jessen J, Petersen OW. Induction of α-smooth muscle actin by transforming growth factor -β1 in quiescent human breast gland fibroblasts. Lab Invest 1993; 68: 696
17. Diamond JR, van-Goor H, Ding G, Engelmyer E. Myofibroblasts in experimental hydronephrosis. Am J Pathol 1995; 146: 121-129
18. Kobayashi Y, Hiki Y, Kokubo T, Horii A, Tateno S. Steroid therapy during the early stage of progressive IgA nephropathy: A 10-year follow up study. Nephron 1996; 72: 237-242
19. Floege J, Eng E, Young BA, Couser WG, Johnson RJ. Heparin suppresses mesangial cell prolifertion and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 1993; 43: 369-380
20. Desmouliere A, Rubbia-Brandt L, Grau G, Gabbiani G. Heparin induces α-smooth muscle actin expression in cultured fibroblasts and in granulation tissue myofibroblasts. Lab Invest 1992; 67: 716-725
21. Yano H, Hayashi T, Momiyama H et al. Transcriptional regulation of the chicken caldesmon gene. J Biol Chem 1995; 270: 23661-23666
22. Blank RS, McQuinn TC, Yin KC et al. Elements of the smooth muscle α-actin promoter required in cis for transcriptional activation in smooth muscle. J Biol Chem 1992; 267: 984-989
23. Kawada N, Moriyama T, Ando A et al. The role of intron 1 in smooth muscle α-actin transcriptional regulation in activated mesangial cells in vivo. Kidney Int (in press)